Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: J Neurochem. 2013 Aug 19;128(1):152–161. doi: 10.1111/jnc.12378

Figure 1.

Figure 1

Systemic AMPH (1 mg/kg i.p.) administration caused a significant rise in locomotor activity compared to a group which received AMPH (1 mg/kg i.p.) in addition to VL perfusion of TTX (10 μM; black bar). Data are expressed as locomotor counts ± SEM.

*p<0.05, AMPH-only time point significantly different from AMPH + TTX treated group

**p<0.01, AMPH-only time point significantly different from AMPH + TTX treated group